Cleared Traditional

K251973 - Luminance Red Cold Sore Device (TN1927G) (FDA 510(k) Clearance)

Sep 2025
Decision
89d
Days
Class 2
Risk

K251973 is an FDA 510(k) clearance for the Luminance Red Cold Sore Device (TN1927G). This device is classified as a Light Based Treatment For Cold Sores Herpes Simplex Virus-1 (Class II - Special Controls, product code OKJ).

Submitted by Luminance Medical Ventures, Inc. (Dallas, US). The FDA issued a Cleared decision on September 23, 2025, 89 days after receiving the submission on June 26, 2025.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4860. Shortens Time To Healing Of Herpes Simplex Lesions On The Lips, With Time To Healing Defined As The Time To Patient Described Re-epithelialization..

Submission Details

510(k) Number K251973 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 2025
Decision Date September 23, 2025
Days to Decision 89 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OKJ - Light Based Treatment For Cold Sores Herpes Simplex Virus-1
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4860
Definition Shortens Time To Healing Of Herpes Simplex Lesions On The Lips, With Time To Healing Defined As The Time To Patient Described Re-epithelialization.